| AZD1480 |
Influence on apoptosis |
MTS |
1.00 µM |
HD-LM2 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on apoptosis |
MTS |
1.00 µM |
L-428 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on apoptosis |
MTS |
1.00 µM |
KM-H2 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on apoptosis |
MTS |
1.00 µM |
L-540 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on apoptosis |
MTS |
5.00 µM |
HD-LM2 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on apoptosis |
MTS |
5.00 µM |
L-428 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on apoptosis |
MTS |
5.00 µM |
KM-H2 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on apoptosis |
MTS |
5.00 µM |
L-540 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
N/A N/A |
ARPE19 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
N/A N/A |
HEK293 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
N/A N/A |
KCNR |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
N/A N/A |
SY5Y |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
N/A N/A |
BE2 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
N/A N/A |
AS |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
N/A N/A |
NGP |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
N/A N/A |
IMR32 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
N/A N/A |
LAN5 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
1.00 µM |
CLBL-1 |
Canis lupus familiaris |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
2.00 µM |
CLBL-1 |
Canis lupus familiaris |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
5.00 µM |
CLBL-1 |
Canis lupus familiaris |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
1.00 µM |
CLBL-1 |
Canis lupus familiaris |
patient 1 |
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
2.00 µM |
CLBL-1 |
Canis lupus familiaris |
patient 1 |
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
5.00 µM |
CLBL-1 |
Canis lupus familiaris |
patient 1 |
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
1.00 µM |
CLBL-1 |
Canis lupus familiaris |
patient 2 |
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
2.00 µM |
CLBL-1 |
Canis lupus familiaris |
patient 2 |
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
5.00 µM |
CLBL-1 |
Canis lupus familiaris |
patient 2 |
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
1.00 µM |
CLBL-1 |
Canis lupus familiaris |
patient 3 |
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
2.00 µM |
CLBL-1 |
Canis lupus familiaris |
patient 3 |
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
5.00 µM |
CLBL-1 |
Canis lupus familiaris |
patient 3 |
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
1.00 µM |
OCL-LY7 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
2.00 µM |
OCL-LY7 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell proliferation |
MTS Assay |
5.00 µM |
OCL-LY7 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell viability |
MTS Assay |
0.10 µM |
LN-17 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell viability |
MTS Assay |
0.50 µM |
LN-17 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell viability |
MTS Assay |
1.00 µM |
LN-17 |
Homo sapiens |
|
|
|
| AZD1480 |
Influence on cell viability |
MTS Assay |
0.50 µM |
786-O |
Mus musclus |
|
|
|
| AZD1480 |
Influence on cell viability |
MTS Assay |
1.00 µM |
786-O |
Mus musclus |
|
|
|
| AZD1480 |
Influence on cell viability |
MTS Assay |
0.50 µM |
Renca |
Mus musclus |
|
|
|
| AZD1480 |
Influence on cell viability |
MTS Assay |
1.00 µM |
Renca |
Mus musclus |
|
|
|
| AZD1480 |
Cell viability inhibition |
MTS Assay |
0.50 µM |
U266 |
Homo sapiens |
|
|
|
| AZD1480 |
Cell viability inhibition |
MTS Assay |
0.50 µM |
RPMI 8226 |
Homo sapiens |
|
|
|
| AZD1480 |
Cell viability inhibition |
MTS Assay |
0.50 µM |
Kms.11 |
Homo sapiens |
|
|
|
| AZD1480 |
Cell viability inhibition |
MTS Assay |
1.00 µM |
U266 |
Homo sapiens |
|
|
|
| AZD1480 |
Cell viability inhibition |
MTS Assay |
1.00 µM |
RPMI 8226 |
Homo sapiens |
|
|
|
| AZD1480 |
Cell viability inhibition |
MTS Assay |
1.00 µM |
Kms.11 |
Homo sapiens |
|
|
|
| AZD1480 |
Cell viability inhibition |
MTS Assay |
2.00 µM |
U266 |
Homo sapiens |
|
|
|
| AZD1480 |
Cell viability inhibition |
MTS Assay |
2.00 µM |
RPMI 8226 |
Homo sapiens |
|
|
|
| AZD1480 |
Cell viability inhibition |
MTS Assay |
2.00 µM |
Kms.11 |
Homo sapiens |
|
|
|
| AZD1480 |
Cell viability inhibition |
MTS Assay |
3.00 µM |
U266 |
Homo sapiens |
|
|
|
| AZD1480 |
Cell viability inhibition |
MTS Assay |
3.00 µM |
RPMI 8226 |
Homo sapiens |
|
|
|
